Molecular mimicry and the pathogenesis of insulin-dependent diabetes mellitus: Still just an attractive hypothesis

Annals of Medicine

Volumn 29, Issue 5, 1997, Pages 393-399

  Atkinson, Mark A ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Autoimmunity; Cellular immunity; Diabetes; Molecular mimicry

Indexed keywords

GLUTAMATE DECARBOXYLASE; INSULIN;

AMINO ACID SEQUENCE; AUTOIMMUNITY; CELLULAR IMMUNITY; ETIOLOGY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MEDICAL LITERATURE; MOLECULAR MIMICRY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW;

EID: 0030684014     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899708999368     Document Type: Review

References (26)

1. Atkinson MA, Maclaren NK. The pathogenesis of insulin-dependent diabetes mellitus. N Engt J Med 1994; 331: 1428-36.
2. Green A, Gale EAM, Patterson CC. Incidence of childhood-onset insulin-dependent diabetes mellitus: the EURODIAB ACE study. Lancet 1992; 339: 905-9.
3. Maclaren NK, Atkinson MA. Is insulin-dependent diabetes mellitus environmentally induced? N Engl J Med 1992; 327: 348-9.
4. Castano L, Eisenbarth GS. Type-1 diabetes: a chronic autoimmune disease of human, mouse, and rat. Annu Rev Immunol 1990; 8: 647-79.
5. Foulis AK, Liddle CN, Farquharson MA, Richmond JA, Weir RS. The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25 year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia 1986; 29: 267-74.
6. Wicker LS, Todd JA, Peterson LB. Genetic control of autoimmune diabetes in the NOD mouse. Annu Rev Immunol 1995; 13: 179-200.
7. Tisch R, McDevitt H. Insulin-dependent diabetes mellitus. Cell 1996; 85: 291-7.
8. Mossman TR, Coffman RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7: 145-73.
9. Rabinovich A. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation. Diabetes 1994; 43: 613-21.
10. Harrison. LC, Honeymoon MC, DeAizpurua HJ, et at. Inverse relationship between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin dependent diabetes. Lancet 1993; 341: 1365-9.
11. Oldstone MBA. Molecular mimicry as a mechanism for the cause and as a probe uncovering etiologic agent(s) of autoimmune disease. Curr Top Microblol Immunol 1989; 145: 127-35.
12. Porcelli S. Molecular mimicry and the generation of autoimmune diseases. Rheumatol Rev 1993; 2: 41-50.
13. Baum H. Autoimmune disease and molecular mimicry: an hypotheses. Trends Biochem Sci 1993; 18: 140-4.
14. Wucherpfennig KW, Stromenger JL. Molecular mimicry in T-cell mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995; 80: 695-705.
15. Hughes RA, Keat AC. Reiter's syndrome and reactive arthritis: a current view. Semin Arthritis Rheum 1994; 24: 190-210.
16. Lehmann PV, Sercarz EE, Forsthubert T, Dayan CH, Gammon G, Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol Today 1993; 14: 203-8.
17. Miller JFAP, Morahan G. Peripheral T cell tolerance. Annu Rev Immunol 1992; 10: 51-70.
18. Kaurman DL, Clare-Salzler MC, Tian J, et al. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 1993; 366: 69-72.
19. Tisch R, Yang XD, Singer SM, et al. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 1993; 366: 72-5.
20. Soctt FW, Norris JM, Kolb H. Milk and type 1 diabetes. Diabetes Care 1996; 19: 379-83.
21. Baum H, Davies H, Peakman M. Molecular mimicry in the MHC: hidden clues to autoimmunity? Immunol Today 1996; 17: 64-70.
22. Szopa TM, Tichener PA, Portwood ND, Taylor KW. Diabetes mellitus due to viruses - some recent developments. Diabetologia 1993; 36: 687-95.
23. Graves PM, Norris JM, Pallansch MA, Gerling IC, Rewers M. The role of enteroviral infections in the development of IDDM. Limitations of current approaches. Diabetes 1997; 46: 161-8.
24. Ellis TM, Atkinson MA. The clinical significance of an autoimmune response against glutamic acid decarboxylase. Nat Med 1996; 2: 148-53.
25. Kaufman DL, Erlander MG, Clare-Salzler M, et al. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest 1992; 89: 283-92.
26. Jones DB, Crosby I. Proliferative lymphocyte responses to virus antigens homologous to GAD65 in IDDM. Diabetologia 1996; 39: 1318-24.